COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds.
COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds.
If a manufacturer has received public funding, they are feeling the effects of the stock market downturn and may need to find ways to decrease budget and/or bring about additional funding sources.
Our team took a look at the most recent pharmaceutical developments from the week, including where we are with treatment options and how manufacturers are racing to find an effective treatment for COVID-19.
To Our Community, Like many of you, we’ve had to be flexible and responsive during the past couple of weeks and plan to continue doing so as the COVID-19 pandemic unfolds in the weeks and months ahead.
